Today, our COO Ryan Fischer will join the White House Clinical Trials Forum organized by the White House Office of Science & Technology Policy.
The meeting convenes key health leaders, advocates, physicians, researchers, and administration officials to discuss challenges and identify new federal and private actions to improve clinical trial participation and access and foster equity in biomedical research.
Goals for the forum include:
Sharing developments from the Biden- Harris Administration and learning from one another to accelerate progress;
Elevating best practices for people-centered clinical trial design and incorporating the expertise of clinical trial participants as partners in research; and
Building on the momentum of recent progress to address shared challenges in expanding access to and participation in clinical trials.
We are excited Angelman syndrome will be represented at the forum. You can listen to the opening discussion from 10:00-11:00am ET here.